Page 72 - IJB-8-4
P. 72

3D Bioprinting for Anticancer Drug Screening
               https://doi.org/10.1039/c8lc00796a                  Specific Responses to Chemoradiotherapy. Nat Biomed Eng,
           118.  Nguyen T, et al., 2019, Robust chemical bonding of PMMA   3:509–519.
               microfluidic devices to porous PETE membranes for reliable      https://doi.org/10.1038/s41551-019-0363-x
               cytotoxicity testing of drugs. Lab Chip, 19:3706–13.  130.  Xie M, Gao Q, Fu J, et al., 2020, Bioprinting of Novel 3D Tumor
               https://doi.org/10.1039/c9lc00338j                  Array Chip for Drug Screening. Biodes Manuf, 3:175–88.
           119.  Dababneh AB, Ozbolat  IT, 2014, Bioprinting  Technology:      https://doi.org/10.1007/s42242-020-00078-4
               A  Current State-of-the-art  Review.  J  Manuf Sci Eng,   131.  Komen J, van Neerven SM, van den Berg A, et al., 2021,
               136:061016.                                         Mimicking and Surpassing the Xenograft Model with Cancer-
           120.  Xu F, Celli J, Rizvi I,  et al.,  2011, A  Three-Dimensional   on-chip Technology. EBioMedicine, 66:103303.
               In Vitro Ovarian Cancer Coculture Model Using a High-     https://doi.org/10.1016/j.ebiom.2021.103303
               Throughput Cell Patterning Platform. Biotechnol J, 6:204–12.  132.  Maulana  TI, Kromidas E,  Wallstabe L,  et al., 2021,
               https://doi.org/10.1002/biot.201000340              Immunocompetent Cancer-on-chip Models to  Assess
           121.  Keenan TM, Folch A, 2008, Biomolecular Gradients in Cell   Immuno-oncology Therapy. Adv Drug Del Rev, 173:281–305.
               Culture Systems. Lab Chip, 8:34–57.                 https://doi.org/10.1016/j.addr.2021.03.015
               https://doi.org/10.1039/b711887b                133.  Krishnamoorthy M, Gerhardt L,  Vareki SM, 2021,
           122.  Monteiro  MV, Zhang  YS, Gaspar  VM,  et al., 2021,   Immunosuppressive Effects of Myeloid-Derived Suppressor
               3D-Bioprinted Cancer-on-a-chip: Level-Up Organotypic   Cells in Cancer and Immunotherapy. Cells, 10:1170.
               In  Vitro Models. Trends Biotechnol, 40:432–47.     https://doi.org/10.3390/cells10051170
               https://doi.org/10.1016/j.tibtech.2021.08.007   134.  Kumar SA, Delgado M, Mendez VE, et al., 2019, Applications
           123.  Hamid Q, Wang C, Zhao Y, et al., 2014, A Three-dimensional   of Stem Cells and Bioprinting  for Potential  Treatment  of
               Cell-laden Microfluidic Chip for In Vitro Drug Metabolism   Diabetes. World J Stem Cells, 11:13–32.
               Detection. Biofabrication, 6:025008.                https://doi.org/10.4252/wjsc.v11.i1.13
               https://doi.org/10.1088/1758-5082/6/2/025008    135.  Jovic  TH,  Combellack  EJ,  Jessop ZM,  et  al.,  2020,  3D
           124.  Hamid Q,  Wang C, Snyder J,  et al., 2015, Maskless   Bioprinting and the Future of Surgery. Front Surg, 7:609836.
               Fabrication of Cell-laden Microfluidic Chips with Localized      https://doi.org/10.3389/fsurg.2020.609836
               Surface Functionalization for the Co-culture of Cancer Cells.   136.  Izumchenko E, Paz K,  Ciznadija D,  et al., 2017, Patient-
               Biofabrication, 7:015012.                           derived xenografts effectively capture responses to oncology
               https://doi.org/10.1088/1758-5090/7/1/015012        therapy in a heterogeneous  cohort of patients  with solid
           125.  Zhang J, Chen F, He Z, et al., 2016, A Novel Approach for   tumors. Ann Oncol, 28:2595–605.
               Precisely Controlled Multiple Cell Patterning in Microfluidic      https://doi.org/10.1093/annonc/mdx416
               Chip by Inkjet Printing and Detection of Drug Metabolism   137.  Zhang N, Yin Y, Xu SJ, et al., 2008, 5-Fluorouracil: Mechanisms
               and Diffusion. Analyst, 141:395.                    of resistance and reversal strategies. Molecules, 13:1551–69.
               https://doi.org/10.1088/1758-5090/7/1/015012        https://doi.org/10.3390/molecules13081551
           126.  Cheng F, Cao X, Li H,  et al., 2019, Generation  of Cost-  138.  Boso D, Maghin  E,  Carraro  E,  et  al., 2020, Extracellular
               effective Paper-based Tissue Models Through Matrix-assisted   matrix-derived hydrogels as biomaterial for different skeletal
               Sacrificial 3D Printing. Nano Lett, 19:3603–11.     muscle tissue replacements. Materials (Basel), 13: 2483
               https://doi.org/10.1021/acs.nanolett.9b00583.s001     https://doi.org/10.3390/ma13112483
           127.  Li Y, Zhang T, Pang Y, et al., 2019, 3D Bioprinting of Hepatoma   139.  Weissleder R, Pittet  MJ, 2008, Imaging in the Era of
               Cells and Application with Microfluidics for Pharmacodynamic   Molecular Oncology. Nature, 452:580–9.
               Test of Metuzumab. Biofabrication, 11:034102.       https://doi.org/10.1038/nature06917
               https://doi.org/10.1088/1758-5090/ab256c
           128.  Mi S, Yang S, Liu T, et al., 2019, A Novel Controllable Cell
               Array  Printing  Technique  on  Microfluidic  Chips.  Trans
               Biomed Eng, 66:2512–20.                        Publisher’s note
               https://doi.org/10.1109/tbme.2019.2891016      Whioce  Publishing remains neutral  with regard to
           129.  Yi HG, Jeong  YH, Kim  Y,  et al., 2019,  A Bioprinted   jurisdictional claims in published maps and institutional
               Glioblastoma-on-a-chip  for  the  Identification  of  Patient-  affiliations.

           64                          International Journal of Bioprinting (2022)–Volume 8, Issue 4
   67   68   69   70   71   72   73   74   75   76   77